The homologous carboxyl-terminal domains of microtubule-associated protein 2 and Tau induce neuronal dysfunction and have differential fates in the evolution of neurofibrillary tangles

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Xie, Ce ^a   Miyasaka, Tomohiro ^a   Yoshimura, Satomi ^a   Hatsuta, Hiroyuki ^c   Yoshina, Sawako ^b   Kage Nakadai, Eriko ^b   Mitani, Shohei ^b   Murayama, Shigeo ^c   Ihara, Yasuo ^a  

^a DOSHISHA UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; TAU PROTEIN; MICROTUBULE ASSOCIATED PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CAENORHABDITIS ELEGANS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; TAUOPATHY; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CAENORHABDITIS ELEGANS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; TAU PROTEINS; TAUOPATHIES;

EID: 84896130231     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089796     Document Type: Article

References (43)

1. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24: 1121-59. (Pubitemid 32695256)
2. Mandelkow EM, Mandelkow E (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2(7): a006247.
3. Kondo J, Honda T, Mori H, Hamada Y, Miura R, et al. (1988) The carboxyl third of tau is tightly bound to paired helical filaments. Neuron 1: 827-34.
4. Wischik CM, Novak M, Thøgersen HC, Edwards PC, Runswick MJ, et al. (1988) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA 85: 4506-10.
5. Wolfe MS (2009) Tau mutations in neurodegenerative diseases. J Biol Chem. 284(10): 6021-5.
6. Amadoro G, Serafino AL, Barbato C, Ciotti MT, Sacco A, et al. (2004) Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons. Cell Death Differ 11: 217-30. (Pubitemid 38159646)
7. Kanaan NM, Morfini G, Pigino G, LaPointe NE, Andreadis A, et al. (2012) Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiol Aging 33: 826.e15-30.
8. Park SY, Ferreira A (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 25: 5365-75.
9. Hirokawa N, Funakoshi T, Sato-Harada R, Kanai Y (1996) Selective stabilization of tau in axons and microtubule-associated protein 2C in cell bodies and dendrites contributes to polarized localization of cytoskeletal proteins in mature neurons. J Cell Biol 132: 667-79. (Pubitemid 26069246)
10. Kanai Y, Hirokawa N (1995) Sorting mechanisms of tau and MAP2 in neurons: suppressed axonal transit of MAP2 and locally regulated microtubule binding. Neuron 14: 421-32.
11. Dehmelt L, Halpain S (2004) The MAP2/Tau family of microtubule-associated proteins. Genome Biol 6: 204.
12. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, et al. (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369: 488-91. (Pubitemid 24210568)
13. Teng J, Takei Y, Harada A, Nakata T, Chen J, et al. (2001) Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization. J Cell Biol 155: 65-76. (Pubitemid 34286208)
14. Brandt R, Gergou A, Wacker I, Fath T, Hutter H (2009) A Caenorhabditis elegans model of tau hyperphosphorylation: induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau. Neurobiol Aging 30: 22-33.
15. Calahorro F, Ruiz-Rubio M (2011) Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder. Invert Neurosci 11: 73-83.
16. Fatouros C, Pir GJ, Biernat J, Koushika SP, Mandelkow E, et al. (2012) Inhibition of tau aggregation in a novel Caenorhabditiselegans model of tauopathy mitigates proteotoxicity. Hum Mol Genet 21: 3587-603.
17. Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, et al. (2003) Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc. Natl. Acad. Sci. USA 100: 9980-5. (Pubitemid 37087054)
18. Miyasaka T, Ding Z, Gengyo-Ando K, Oue M, Yamaguchi H, et al. (2005a) Progressive neurodegeneration in C. elegans model of tauopathy. Neurobiol Dis 20: 372-83. (Pubitemid 41476263)
19. Maduro M, Pilgrim D (1995) Identification and cloning of unc-119, a gene expressed in the Caenorhabditis elegans nervous system. Genetics 141:977-88.
20. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71-94.
21. Mello C, Fire A (1995) DNA transformation. Methods Cell Biol 48: 451-82.
22. Mitani S (1995) Genetic regulation of mec-3 gene expression implicated in the specification of the mechanosensory neuron cell types in Caenorhabditis elegans. Dev Growth Diff 37: 551-557.
23. Miyasaka T, Sato S, Tatebayashi Y, Takashima A (2010) Microtubule destruction induces tau liberation and its subsequent phosphorylation. FEBS Lett 584:3227-32.
24. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-59.
25. Miyasaka T, Watanabe A, Saito Y, Murayama S, Mann DM, et al. (2005b) Visualization of newly deposited tau in neurofibrillary tangles and neuropil threads. J Neuropathol Exp Neurol 64: 665-74. (Pubitemid 41177107)
26. Maeda S, Sahara N, Saito Y, Murayama M, Yoshiike Y, et al. (2007) Granular tau oligomers as intermediates of tau filaments. Biochemistry. 46:3856-61. (Pubitemid 46493485)
27. Yoshida H., Ihara Y (1993) Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau. J Neurochem 61: 1183-6. (Pubitemid 23241267)
28. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, et al. (1995) Hyperphosphorylation of tau in PHF. Neurobiol Aging 16: 365-71.
29. Endoh R, Ogawara M, Iwatsubo T, Nakano I, Mori H (1993) Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease. Brain Res 601:164-72. (Pubitemid 23047678)
30. Watanabe A, Takio K, Ihara Y (1999) Deamidation and isoaspartate formation in smeared tau in paired helical filaments.Unusual properties of the microtubule-binding domain of tau. J Biol Chem 274:7368-78.
31. Ashford JW, Soultanian NS, Zhang SX, Geddes JW (1998) Neuropil threads are collinear with MAP2 immunostaining in neuronal dendrites of Alzheimer brain. J Neuropathol Exp Neurol 57: 972-8. (Pubitemid 28478007)
32. Dammerman M, Yen SH, Shafit-Zagardo B (1989) Sequence of a human MAP-2 region sharing epitopes with Alzheimer neurofibrillary tangles. J Neurosci Res 24: 487-95. (Pubitemid 20015339)
33. Kosik KS, Duffy LK, Dowling MM, Abraham C, McCluskey A, et al. (1984) Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles. Proc Natl Acad Sci USA 81: 7941-5. (Pubitemid 15169178)
34. Rosemblatt M, Fellous A, Mazie JC, Delacourte A, Defossez A (1989) Alzheimer's disease: microtubule-associated proteins 2 (MAP2) are not components of paired helical filaments. FEBS Lett 252: 91-4. (Pubitemid 19201081)
35. Nukina N, Kosik KS, Selkoe DJ (1987) Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. Proc. Natl. Acad. Sci. USA 84: 3415-9. (Pubitemid 17085414)
36. Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87: 5827-5831
37. Lee VM, Balin BJ, Otvos L Jr, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 251:675-8. (Pubitemid 21916893)
38. Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, et al. (2005) Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function. Science. 309: 476-481. (Pubitemid 40994688)
39. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, et al. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41: 17-24. (Pubitemid 27057088)
40. Lippa CF, Zhukareva V, Kawarai T, Uryu K, Shafiq M, et al. (2000) Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation. Ann Neurol 48: 850-8
41. Neumann M, Schulz-Schaeffer W, Crowther RA, Smith MJ, Spillantini MG, et al. (2001) Pick's disease associated with the novel Tau gene mutation K369I. Ann Neurol 50:503-13. (Pubitemid 32938895)
42. Nicholl DJ, Greenstone MA, Clarke CE, Rizzu P, Crooks D, et al. (2001) An English kindred with a novel recessive tauopathy and respiratory failure. Ann Neurol 54:682-6. (Pubitemid 37346077)
43. Pickering-Brown SM, Baker M, Nonaka T, Ikeda K, Sharma S, et al. (2004) Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene. Brain 127:1415-26. (Pubitemid 38745519)